ProCE Banner Activity

Strategies to Mitigate Adverse Events With Asparaginase Treatment in Patients With ALL

Slideset Download
Download this slideset from a live CCO symposium for an expert overview of adverse events associated with asparaginase-based therapy in patients with ALL, including factors contributing to their development.

Released: June 06, 2022

Expiration: June 05, 2023

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Emily Curran, MD

Assistant Professor
Division of Hematology/Oncology
Medical Director, UCC Clinical Trials Office
University of Cincinnati Cancer Center
Cincinnati, Ohio

Emily Curran, MD, has disclosed that she has received consulting/advisor/speaker fees from Amgen, Incyte, Kite, Pfizer, Servier, and Tempus.